ORNA
Live / Registered — Registered (as of 19 Dec 2023)
What this means for you
Registered since 19 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88827351
- Registration number
- 7249621
- Mark type
- Stylized text
- Filed
- 09 Mar 2020
- Published for opposition
- 07 Jul 2020
- Registered
- 19 Dec 2023
- Attorney of record
- Jonathan M. Gelchinsky
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer, autoimmune, immune mediated, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the treatment of cancer, autoimmune, immune mediated, immune system related, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the prevention and treatment of viral and infectious diseases; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for therapeutic vaccines
- Class 042 — Scientific and technological services: Scientific research in the fields of nucleic acid pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics
Owner
- ORNA THERAPEUTICS, INC., Cambridge, MA, US
- ORNA THERAPEUTICS, INC., Cambridge, MA, US
- Oroboros, Inc., Cambridge, MA, US
- Oroboros, Inc., Cambridge, MA, US
Prosecution history
- 19 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 14 Nov 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Nov 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Aug 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Jul 2023 — USE AMENDMENT FILED
- 26 Jul 2023 — TEAS STATEMENT OF USE RECEIVED
- 11 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2023 — SOU EXTENSION 5 GRANTED
- 01 Mar 2023 — SOU EXTENSION 5 FILED
- 04 Apr 2023 — NOTICE OF REVIVAL - E-MAILED
- 04 Apr 2023 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 04 Apr 2023 — PETITION TO REVIVE-GRANTED
- 04 Apr 2023 — TEAS PETITION TO REVIVE RECEIVED
- 03 Apr 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED